Hidradenitis suppurativa and pemphigus: a cross-sectional study

[1]  K. Amber,et al.  Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review , 2020, International journal of dermatology.

[2]  E. Schmidt,et al.  Pemphigus , 2019, The Lancet.

[3]  B. N. Akay,et al.  Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy , 2019, Dermatologic therapy.

[4]  C. Chi,et al.  Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. , 2019, JAMA dermatology.

[5]  M. Romanelli,et al.  Potential role of serum amyloid A in hidradenitis suppurativa , 2019, JAAD case reports.

[6]  K. Kridin,et al.  The coexistence of pemphigus and psoriasis: a systematic review and meta-analysis , 2018, Immunologic Research.

[7]  N. Riedemann,et al.  Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis? , 2018, The British journal of dermatology.

[8]  K. Amber,et al.  Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris , 2018, Front. Immunol..

[9]  L. Pescitelli,et al.  Hidradenitis suppurativa and associated diseases. , 2018, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[10]  M. Khamaisi,et al.  Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study , 2018, Immunologic research.

[11]  M. Khamaisi,et al.  Autoimmune Thyroid Diseases and Thyroid Cancer in Pemphigus: A Big Data Analysis , 2018, Front. Med..

[12]  D. McGonagle,et al.  Hidradenitis suppurativa as an autoinflammatory keratinization disease. , 2018, The Journal of allergy and clinical immunology.

[13]  K. Kridin.  Pemphigus group: overview, epidemiology, mortality, and comorbidities , 2018, Immunologic research.

[14]  A. Garg,et al.  Incidence of hidradenitis suppurativa among tobacco smokers: a population‐based retrospective analysis in the U.S.A. , 2018, The British journal of dermatology.

[15]  D. Ye,et al.  Association between HLA-DQB1 polymorphisms and pemphigus vulgaris: A meta-analysis , 2018, Immunological investigations.

[16]  A. Martorell,et al.  Recommendations for the management of comorbidity in hidradenitis suppurativa , 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  K. Kridin,et al.  Association between pemphigus and psoriasis: A population‐based large‐scale study , 2017, Journal of the American Academy of Dermatology.

[18]  K. Kridin,et al.  Ulcerative colitis associated with pemphigus: a population-based large-scale study , 2017, Scandinavian journal of gastroenterology.

[19]  S. Thomsen,et al.  Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne , 2017, International journal of dermatology.

[20]  D. Kastner,et al.  The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation , 2017, Nature Immunology.

[21]  C. Chams‐Davatchi,et al.  Koebner phenomenon in pemphigus vulgaris patients , 2016, JAAD case reports.

[22]  S. Langan,et al.  Comorbidities and inpatient mortality for pemphigus in the U.S.A. , 2016, The British journal of dermatology.

[23]  J. Borbujo,et al.  Severe hidradenitis suppurativa complicated by renal AA amyloidosis , 2016, Clinical and experimental dermatology.

[24]  Neil Pearce,et al.  Analysis of matched case-control studies , 2016, British Medical Journal.

[25]  A. Alikhan.  Hidradenitis Suppurativa. , 2016, JAMA dermatology.

[26]  A. Kimball,et al.  Systemic associations of hidradenitis suppurativa. , 2015, Journal of the American Academy of Dermatology.

[27]  N. Shear,et al.  Pemphigus and associated comorbidities: a cross‐sectional study , 2015, Clinical and experimental dermatology.

[28]  K. Amber,et al.  Immune response in pemphigus and beyond: progresses and emerging concepts , 2015, Seminars in Immunopathology.

[29]  A. Kimball,et al.  Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. , 2014, Journal of the American Academy of Dermatology.

[30]  A. Roselino,et al.  Prevalence of Metabolic Syndrome and its components in a Brazilian sample of pemphigus patients* , 2014, Anais brasileiros de dermatologia.

[31]  L. J. Margesson,et al.  Hidradenitis suppurativa. , 2014, Best practice & research. Clinical obstetrics & gynaecology.

[32]  G. Jemec,et al.  Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa. , 2013, Acta dermato-venereologica.

[33]  J. Laman,et al.  Elevated levels of tumour necrosis factor (TNF)‐α, interleukin (IL)‐1β and IL‐10 in hidradenitis suppurativa skin: a rationale for targeting TNF‐α and IL‐1β , 2011, The British journal of dermatology.

[34]  H. Volk,et al.  Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa , 2011, The Journal of Immunology.

[35]  C. Zouboulis,et al.  Comorbidities of hidradenitis suppurativa (acne inversa) , 2010, Dermato-endocrinology.

[36]  D. Eisen,et al.  Hidradenitis suppurativa: a comprehensive review. , 2009, Journal of the American Academy of Dermatology.

[37]  E. Giamarellos‐Bourboulis,et al.  Altered innate and adaptive immune responses in patients with hidradenitis suppurativa , 2007, The British journal of dermatology.

[38]  B. Sarah,et al.  Pemphigus vulgaris triggered by rifampin and emotional stress. , 2004 .

[39]  S. Brenner,et al.  Pemphigus vulgaris triggered by rifampin and emotional stress. , 2004, Skinmed.

[40]  G. Rennert,et al.  Prevalence of selected chronic diseases in Israel. , 2001, The Israel Medical Association journal : IMAJ.

[41]  J. Lapins,et al.  No human leukocyte antigen-A, -B or -DR association in Swedish patients with hidradenitis suppurativa. , 2001, Acta dermato-venereologica.

[42]  A. Khan,et al.  Koebner phenomenon in pemphigus vulgaris , 1996, The British journal of dermatology.

[43]  Y. Yamashina,et al.  Exacerbation of pemphigus by rifampicin , 1986, The British journal of dermatology.

[44]  R. Gange,et al.  Pemphigus induced by rifampicin , 1976, The British journal of dermatology.